Eamonn O’Brien
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- Chemokine receptors and signaling
- PARP inhibition in cancer therapy
- Colorectal Cancer Treatments and Studies
Papers in
-
- Peroxisome Proliferator-Activated Receptors 1
- Bone Metabolism and Diseases 1
- Genetics 2
- Neurogenetic and Muscular Disorders Research 2
- Co-authors
- Nigel K. Spurr (3 shared papers)Richard D. Kennedy (4 shared papers)Daniel J. Rader (1 shared paper)Warren B. Gefter (1 shared paper)Megan L. Wolfe (1 shared paper)Pieter H.E. Groot (1 shared paper)Ana M. Valdes (1 shared paper)Alistair Williams (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Neuromuscular Disorders (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)RMD Open (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Eamonn O’Brien
12 papers receiving 292 citations
Peers
Comparison fields: 5 of 50
- Reproductive Medicine 89
- Oncology 104
- Genetics 30
- Cancer Research 39
- Pathology and Forensic Medicine 41
Countries citing papers authored by Eamonn O’Brien
This map shows the geographic impact of Eamonn O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eamonn O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eamonn O’Brien more than expected).
Fields of papers citing papers by Eamonn O’Brien
This network shows the impact of papers produced by Eamonn O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eamonn O’Brien. The network helps show where Eamonn O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Eamonn O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 77 | |
| 2 | 2002 | 69 | |
| 3 | 2011 | 52 | |
| 4 | 2016 | 35 | |
| 5 | 2023 | 18 | |
| 6 | 2004 | 16 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2014 | 5 | |
| 10 | 2011 | 5 | |
| 11 | 2022 | 3 | |
| 12 | 2000 | 2 |
About Eamonn O’Brien
Eamonn O’Brien is a scholar working on Molecular Biology, Genetics, Oncology, Rheumatology and Reproductive Medicine, having authored 12 papers that have together received 301 indexed citations. Recurring topics across this work include Neurogenetic and Muscular Disorders Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Spondyloarthritis Studies and Treatments (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Ferroptosis and cancer prognosis (1 paper), Bone Metabolism and Diseases (1 paper), Chemokine receptors and signaling (1 paper) and Quinazolinone synthesis and applications (1 paper). The work is most often cited by research in Reproductive Medicine (89 citations), Oncology (104 citations), Genetics (30 citations), Cancer Research (39 citations) and Pathology and Forensic Medicine (41 citations). Eamonn O’Brien has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Nigel K. Spurr, Richard D. Kennedy, Daniel J. Rader, Warren B. Gefter, Megan L. Wolfe, Pieter H.E. Groot, Ana M. Valdes, Alistair Williams, W. Glenn McCluggage and Caroline O. Michie. Their work appears in journals such as Journal of Clinical Oncology, Neuromuscular Disorders, Arteriosclerosis Thrombosis and Vascular Biology, RMD Open and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.